
SolaScren8%+2%+3%+2
Incepta Pharmaceuticals Ltd.
Padimate O + Avobenzone + Oxybenzone + Titanium dioxide is a broad-spectrum topical sunscreen combination indicated for: Established/OTC-monograph use: Topical application to help prevent sunburn…
Padimate O + Avobenzone + Oxybenzone + Titanium dioxide is a broad-spectrum topical sunscreen combination indicated for:
Padimate O + Avobenzone + Oxybenzone + Titanium dioxide is an over-the-counter (OTC) product regulated under the FDA sunscreen monograph rather than a prescription drug; it is not intended to treat any disease.
| Population | Recommended use |
|---|---|
| Adults and children 6 months of age and older | Apply liberally and evenly to all exposed skin 15-30 minutes before sun exposure. Reapply at least every 2 hours, and immediately after swimming, sweating heavily, or towel-drying. |
| Infants under 6 months | Not recommended for use; see Use in Special Populations. |
Use Padimate O + Avobenzone + Oxybenzone + Titanium dioxide as part of a broader sun protection strategy that includes limiting time in direct sun (especially 10 a.m.-2 p.m.), wearing protective clothing, and seeking shade.
Most users tolerate Padimate O + Avobenzone + Oxybenzone + Titanium dioxide well. Reported adverse effects include:
Discontinue use and consult a physician if irritation, rash, or signs of an allergic reaction develop.
Padimate O + Avobenzone + Oxybenzone + Titanium dioxide is contraindicated in individuals with known hypersensitivity to padimate O, avobenzone, oxybenzone, titanium dioxide, or any other ingredient in the formulation.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.